Dementia — The Effect of Digital Reminiscence Therapy on People With Mild and Moderate Dementia
Citation(s)
Bejan A, Gündogdu R, Butz K, Müller N, Kunze C, König P Using multimedia information and communication technology (ICT) to provide added value to reminiscence therapy for people with dementia : Lessons learned from three field studies. Z Gerontol Geriatr
BUTLER RN The life review: an interpretation of reminiscence in the aged. Psychiatry. 1963 Feb;26:65-76.
Etters L, Goodall D, Harrison BE Caregiver burden among dementia patient caregivers: a review of the literature. J Am Acad Nurse Pract. 2008 Aug;20(8):423-8. doi: 10.1111/j.1745-7599.2008.00342.x. Review.
Folstein MF, Folstein SE, McHugh PR "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189-98.
Fuh JL, Liu CK, Mega MS, Wang SJ, Cummings JL Behavioral disorders and caregivers' reaction in Taiwanese patients with Alzheimer's disease. Int Psychogeriatr. 2001 Mar;13(1):121-8.
GBD 2016 Dementia Collaborators Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019 Jan;18(1):88-106. doi: 10.1016/S1474-4422(
Joddrell P, Astell AJ Studies Involving People With Dementia and Touchscreen Technology: A Literature Review. JMIR Rehabil Assist Technol. 2016 Nov 4;3(2):e10. doi: 10.2196/rehab.5788. Review.
Jones C, Sung B, Moyle W Engagement of a Person with Dementia Scale: Establishing content validity and psychometric properties. J Adv Nurs. 2018 May 17. doi: 10.1111/jan.13717. [Epub ahead of print]
Ko KT, Yip PK, Liu SI, Huang CR Chinese version of the Zarit caregiver Burden Interview: a validation study. Am J Geriatr Psychiatry. 2008 Jun;16(6):513-8. doi: 10.1097/JGP.0b013e318167ae5b.
Lazar A, Thompson H, Demiris G A systematic review of the use of technology for reminiscence therapy. Health Educ Behav. 2014 Oct;41(1 Suppl):51S-61S. doi: 10.1177/1090198114537067. Review.
Lorenz K, Freddolino PP, Comas-Herrera A, Knapp M, Damant J Technology-based tools and services for people with dementia and carers: Mapping technology onto the dementia care pathway. Dementia (London). 2019 Feb;18(2):725-741. doi: 10.1177/14713012176916
Marshall F, Gordon A, Gladman JRF, Bishop S Care homes, their communities, and resilience in the face of the COVID-19 pandemic: interim findings from a qualitative study. BMC Geriatr. 2021 Feb 5;21(1):102. doi: 10.1186/s12877-021-02053-9.
Martinsson L, Strang P, Bergström J, Lundström S Dying from COVID-19 in nursing homes-sex differences in symptom occurrence. BMC Geriatr. 2021 May 6;21(1):294. doi: 10.1186/s12877-021-02228-4.
Moon S, Park K The effect of digital reminiscence therapy on people with dementia: a pilot randomized controlled trial. BMC Geriatr. 2020 May 6;20(1):166. doi: 10.1186/s12877-020-01563-2.
Neal I, du Toit SHJ, Lovarini M The use of technology to promote meaningful engagement for adults with dementia in residential aged care: a scoping review. Int Psychogeriatr. 2020 Aug;32(8):913-935. doi: 10.1017/S1041610219001388. Epub 2019 Sep 24. Revie
Park K, Lee S, Yang J, Song T, Hong GS A systematic review and meta-analysis on the effect of reminiscence therapy for people with dementia. Int Psychogeriatr. 2019 Nov;31(11):1581-1597. doi: 10.1017/S1041610218002168. Epub 2019 Feb 4.
Penning MJ, Wu Z Caregiver Stress and Mental Health: Impact of Caregiving Relationship and Gender. Gerontologist. 2016 Dec;56(6):1102-1113. Epub 2015 Apr 17.
Robinson L, Clare L, Evans K Making sense of dementia and adjusting to loss: psychological reactions to a diagnosis of dementia in couples. Aging Ment Health. 2005 Jul;9(4):337-47.
Schulz KF, Altman DG, Moher D; CONSORT Group CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med. 2010 Jun 1;152(11):726-32. doi: 10.7326/0003-4819-152-11-201006010-00232. Epub 2010 Mar 24.
Stinson CK Structured group reminiscence: an intervention for older adults. J Contin Educ Nurs. 2009 Nov;40(11):521-8. doi: 10.3928/00220124-20091023-10.
Subramaniam P, Woods B Digital life storybooks for people with dementia living in care homes: an evaluation. Clin Interv Aging. 2016 Sep 16;11:1263-1276. eCollection 2016.
Wang JJ Group reminiscence therapy for cognitive and affective function of demented elderly in Taiwan. Int J Geriatr Psychiatry. 2007 Dec;22(12):1235-40.
Whitehead BR, Torossian E Older Adults' Experience of the COVID-19 Pandemic: A Mixed-Methods Analysis of Stresses and Joys. Gerontologist. 2021 Jan 21;61(1):36-47. doi: 10.1093/geront/gnaa126.
Yeung DY, Chung EKH, Lam AHK, Ho AKK Effects of subjective successful aging on emotional and coping responses to the COVID-19 pandemic. BMC Geriatr. 2021 Feb 17;21(1):128. doi: 10.1186/s12877-021-02076-2.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.